SkillCell has developed IDIR^® (IDentification of Insulin Resistance), the first urine test to diagnose insulin resistance. CE-marked and supported by a robust clinical study, IDIR^® addresses the issue of metabolic disorders, a major challenge in public health with very significant socio-economic implications.

IDIR^®’s main indications:

• T2 Diabetes prevention,
• Anticipation of the consequences of obesity,
• NASH investigation.

No more lab, needle, blood sample or waiting time!

IDIR^®'s mission is to provide people with transparent and critical health information, readily accessible, to help them manage their health and avoid the transition from insulin resistance to chronic metabolic diseases, while at the same time encouraging obesity management measures.

Insulin resistance is a condition in which cells have a reduced capacity to respond to the insulin hormone. Insulin resistance is highly correlated to unhealthy dietary habits, sedentary life-styles and obesity. It is often an early condition that leads to chronic diseases such as T2 diabetes or NASH (non-alcoholic steatohepatitis) and their related complications. Insulin resistance is also a condition that can be reversed in a few months. Its diagnosis is therefore a powerful prevention tool for the chronic metabolic diseases mentioned above.

Economic growth and modernization have led to lifestyle-related chronic diseases. Unhealthy dietary habits and the movement from active to sedentary lifestyles are dramatically increasing obesity and insulin resistance in the population, leading to diseases such as T2 diabetes or NASH. The onset of these pathologies is usually slow and difficult to determine, but their complications are extremely harmful and can absorb up to 20% of the entire healthcare budget of several countries, making it one of the biggest global health crises of the 21^st century.